Business Wire | Nov 22, 2021 04:05PM EST

Alpine Immune Sciences Announces Participation in Fireside Chat at the 4th Annual Evercore ISI HealthCONx Conference

Nov. 22, 2021

SEATTLE--(BUSINESS WIRE)--Nov. 22, 2021--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today announced the company will participate in a fireside chat at the 4th Annual Evercore ISI HealthCONx Conference on Wednesday, December 1st, 2021, at 12:35 p.m. ET/9:35 a.m. PT.

A live webcast of the fireside chat will be available online in the investor relations section of the company's website at https://ir.alpineimmunesciences.com/events. A replay of the presentation will be available on the company website for 90 days following the webcast.

About Alpine Immune Sciences, Inc.

Alpine Immune Sciences is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients' lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211122006333/en/

CONTACT: Alpine Immune Sciences, Inc. Contacts: Alex Sharif Director, Investor Relations and Corporate Development Alpine Immune Sciences, Inc. 206.788.4545 ir@alpineimmunesciences.com Kelli Perkins (Media) 310.625.3248 kelli@redhousecomms.com